Percentage of surviving infants who received the third dose of in Algeria
Algeria: Percentage of surviving infants who received the third dose of was 94 in 2025. ▼ Falling
Latest (2025)
94
Change on year
up 2.2%
World rank
13th
of 20 countries
All-time high
95
in 2009
All-time low
77
in 2022
Years of data
18
2008–2025
Percentage of surviving infants who received the third dose of in Algeria, 2008–2025
Source: UNICEF.
Analysis
In 2025, percentage of surviving infants who received the third dose of in Algeria stood at 94.
That represents a change of up 2.2% on the previous year and down 1.1% over ten years.
Over the whole period, percentage of surviving infants who received the third dose of in Algeria peaked at 95 in 2009 and was at its lowest, 77, in 2022.
That places Algeria 13th out of 20 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently falling across the 18 years of available data.
Percentage of surviving infants who received the third dose of in Algeria, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 93 | — |
| 2009 | 95 | +2.2% |
| 2010 | 95 | +0.0% |
| 2011 | 95 | +0.0% |
| 2012 | 95 | +0.0% |
| 2013 | 95 | +0.0% |
| 2014 | 95 | +0.0% |
| 2015 | 95 | +0.0% |
| 2016 | 91 | -4.2% |
| 2017 | 91 | +0.0% |
| 2018 | 91 | +0.0% |
| 2019 | 88 | -3.3% |
| 2020 | 84 | -4.5% |
| 2021 | 81 | -3.6% |
| 2022 | 77 | -4.9% |
| 2023 | 92 | +19.5% |
| 2024 | 92 | +0.0% |
| 2025 | 94 | +2.2% |
Algeria compared with similar countries
- Algeria's 94 is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 96, 98% of the median. (19 countries reporting)
- Algeria's 94 is above the median for upper middle income countries, which is 94, 1.0× the median. (5 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 94 | 93 | 95 | 2 |
| 2010s | 93.1 | 88 | 95 | 10 |
| 2020s | 86.67 | 77 | 94 | 6 |
Countries ranked near Algeria
More health data for Algeria
- Un projection of annual infant deaths, annual growth rate -1.82 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5437 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 943.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,455 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.77 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0465 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is percentage of surviving infants who received the third dose of in Algeria?
- Percentage of surviving infants who received the third dose of in Algeria was 94 in 2025, according to UNICEF.
- What is the highest percentage of surviving infants who received the third dose of recorded in Algeria?
- The highest recorded value was 95 in 2009.
- What is the lowest percentage of surviving infants who received the third dose of recorded in Algeria?
- The lowest recorded value was 77 in 2022.
- How does Algeria rank for percentage of surviving infants who received the third dose of?
- Algeria ranks 13th out of 20 countries with data for 2025.
- Is percentage of surviving infants who received the third dose of rising or falling in Algeria?
- Over the last ten years it is down 1.1%. The long-run trend across the full record is falling.
- Where does this Algeria data come from?
- The figures come from UNICEF, published as part of Percentage of surviving infants who received the third dose of Hib-containing vaccine. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under UNICEF Terms of Use (attribution required).